These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26974368)

  • 1. Caring for Coronary Artery Disease in China: Managing Modernization.
    Blumenthal D; Hsiao W; Blumenthal DM
    JAMA Intern Med; 2016 Apr; 176(4):521-3. PubMed ID: 26974368
    [No Abstract]   [Full Text] [Related]  

  • 2. Coronary Catheterization and Percutaneous Coronary Intervention in China: 10-Year Results From the China PEACE-Retrospective CathPCI Study.
    Zheng X; Curtis JP; Hu S; Wang Y; Yang Y; Masoudi FA; Spertus JA; Li X; Li J; Dharmarajan K; Downing NS; Krumholz HM; Jiang L;
    JAMA Intern Med; 2016 Apr; 176(4):512-21. PubMed ID: 26974883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.
    Giustino G; Baber U; Stefanini GG; Aquino M; Stone GW; Sartori S; Steg PG; Wijns W; Smits PC; Jeger RV; Leon MB; Windecker S; Serruys PW; Morice MC; Camenzind E; Weisz G; Kandzari D; Dangas GD; Mastoris I; Von Birgelen C; Galatius S; Kimura T; Mikhail G; Itchhaporia D; Mehta L; Ortega R; Kim HS; Valgimigli M; Kastrati A; Chieffo A; Mehran R
    Am J Cardiol; 2015 Sep; 116(6):845-52. PubMed ID: 26174605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinical outcomes according to presentation of angina pectoris versus acute myocardial infarction in patients who underwent a percutaneous coronary intervention with a drug-eluting stent.
    Seo SM; Kim TH; Koh YS; Her SH; Shin DI; Park HJ; Kim PJ; Park CS; Lee JM; Kim DB; Kim HY; Chang K; Yoo KD; Jeon DS; Chung WS; Seung KB;
    Coron Artery Dis; 2016 Mar; 27(2):143-50. PubMed ID: 26693807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete versus incomplete revascularization in patients with multivessel coronary artery disease treated with drug-eluting stents.
    Chang M; Ahn JM; Kim N; Lee PH; Roh JH; Yoon SH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    Am Heart J; 2016 Sep; 179():157-65. PubMed ID: 27595691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of outcomes after percutaneous coronary intervention among different coronary subsets (stable and unstable angina pectoris and ST-segment and non-ST-segment myocardial infarction).
    Loh JP; Pendyala LK; Kitabata H; Torguson R; Omar A; Minha S; Chen F; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2014 Jun; 113(11):1794-801. PubMed ID: 24837256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STEMI patients and non-culprit lesions: what to do and when?
    Smits PC
    EuroIntervention; 2013 Dec; 9(8):895, 897. PubMed ID: 24384285
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of plaque characteristics in narrowings with ST-elevation myocardial infarction (STEMI), non-STEMI/unstable angina pectoris and stable coronary artery disease (from the ADAPT-DES IVUS Substudy).
    Dong L; Mintz GS; Witzenbichler B; Metzger DC; Rinaldi MJ; Duffy PL; Weisz G; Stuckey TD; Brodie BR; Yun KH; Xu K; Kirtane AJ; Stone GW; Maehara A
    Am J Cardiol; 2015 Apr; 115(7):860-6. PubMed ID: 25661569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and Prognostic Implications of Late Bleeding After Myocardial Infarction or Unstable Angina According to Treatment Strategy.
    Brinkert M; Southern DA; James MT; Knudtson ML; Anderson TJ; Charbonneau F
    Can J Cardiol; 2017 Aug; 33(8):998-1005. PubMed ID: 28669702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Usefulness of the Platelet-to-Lymphocyte Ratio and the Neutrophil-to-Lymphocyte Ratio in Predicting the Long-Term Adverse Events in Patients Who Have Undergone Percutaneous Coronary Intervention with a Drug-Eluting Stent.
    Cho KI; Ann SH; Singh GB; Her AY; Shin ES
    PLoS One; 2015; 10(7):e0133934. PubMed ID: 26207383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics, treatment and outcome of patients with non-ST-elevation acute coronary syndromes and multivessel coronary artery disease: observations from PURSUIT (platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrelin therapy).
    Breeman A; Mercado N; Lenzen M; van den Brand MM; Harrington RA; Califf RM; Topol EJ; Simoons ML; Boersma E;
    Cardiology; 2002; 98(4):195-201. PubMed ID: 12566649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of second-generation drug-eluting versus bare-metal stents in octogenarian patients with ST-segment elevation myocardial infarction.
    Piao ZH; Jeong MH; Li Y; Kim MC; Cho KH; Park KH; Sim DS; Kim KH; Hong YJ; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kim YJ; Cho MC; Kim CJ; Kim HS;
    Int J Cardiol; 2014 Dec; 177(3):1081-4. PubMed ID: 25456703
    [No Abstract]   [Full Text] [Related]  

  • 13. PCI with drug-eluting stents ≤ 12 months before surgery was linked to increased MI and cardiac death after surgery.
    Borges FK; Devereaux PJ
    Ann Intern Med; 2017 Mar; 166(6):JC35. PubMed ID: 28320009
    [No Abstract]   [Full Text] [Related]  

  • 14. Let's talk BIG DATA.
    Wijns W; Barbato E
    EuroIntervention; 2016 Oct; 12(9):1081-1082. PubMed ID: 27753594
    [No Abstract]   [Full Text] [Related]  

  • 15. Percutaneous coronary intervention: ever closer to real world silver bullets!?
    Hillegass WB; Brott BC
    Catheter Cardiovasc Interv; 2015 Apr; 85(5):807-8. PubMed ID: 25789729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Outcomes of Transcatheter Aortic Valve Replacement Plus Percutaneous Coronary Intervention Versus Transcatheter Aortic Valve Replacement Alone in the United States.
    Singh V; Rodriguez AP; Thakkar B; Patel NJ; Ghatak A; Badheka AO; Alfonso CE; de Marchena E; Sakhuja R; Inglessis-Azuaje I; Palacios I; Cohen MG; Elmariah S; O'Neill WW
    Am J Cardiol; 2016 Dec; 118(11):1698-1704. PubMed ID: 27665205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ACIRA Registry: A Regional Tool to Improve the Healthcare Pathway for Patients Undergoing Percutaneous Coronary Interventions and Coronary Angiographies in the French Aquitaine Region: Study Design and First Results.
    Lesaine E; Saillour-Glenisson F; Leymarie JL; Jamet I; Fernandez L; Perez C; Legrand JP; Salmi LR; Coste P;
    Crit Pathw Cardiol; 2020 Mar; 19(1):1-8. PubMed ID: 31567554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender disparity in the use of drug-eluting stents during percutaneous coronary intervention for acute myocardial infarction.
    Iyanoye A; Moreyra AE; Swerdel JN; Gandhi SK; Cabrera J; Cosgrove NM; Kostis JB;
    Catheter Cardiovasc Interv; 2015 Aug; 86(2):221-8. PubMed ID: 25645156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overlapping technique for hybrid percutaneous coronary intervention strategy utilising drug eluting stent and ABSORB bioresorbable vascular scaffold.
    Yew KL
    Int J Cardiol; 2015 Jan; 178():e8-e10. PubMed ID: 25205484
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-eluting stents in unprotected left main coronary artery disease.
    Bernelli C
    Expert Rev Cardiovasc Ther; 2014 Nov; 12(11):1349-68. PubMed ID: 25340285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.